Browse > Article

A case of syndrome of inappropriate secretion of antidiuretic hormone associated with paroxetine  

Ahn, Hyo-Jun (Department of Internal Medicine, The Catholic University of Korea School of Medicine)
Kim, Hyung-Wook (Department of Internal Medicine, The Catholic University of Korea School of Medicine)
Kim, Young-Soo (Department of Internal Medicine, The Catholic University of Korea School of Medicine)
Kim, Young-Ok (Department of Internal Medicine, The Catholic University of Korea School of Medicine)
Yoon, Sun-Ae (Department of Internal Medicine, The Catholic University of Korea School of Medicine)
Choi, Jae-Ki (Department of Internal Medicine, The Catholic University of Korea School of Medicine)
Publication Information
The Korean Journal of Medicine / v.79, no.6, 2010 , pp. 710-713 More about this Journal
Abstract
Paroxetine is a well-known selective serotonin reuptake inhibitor, and has been reported to be advantageous for chronic pain control. Paroxetine is increasingly used for various types of chronic pain because of its safety; however, hyponatremia, or syndrome of inappropriate secretion of antidiuretic hormone (SIADH) associated with paroxetine, has been reported. This complication is relatively rare, but some patients have presented with severe neurological symptoms. Here, we report the first case of SIADH associated with paroxetine in Korea.
Keywords
Paroxetine; Syndrome of inappropriate secretion of antidiuretic hormone(SIADH);
Citations & Related Records
연도 인용수 순위
  • Reference
1 Rapaport MH, Schneider LS, Dunner DL, Davies JT, Pitts CD. Efficacy of controlled-release paroxetine in the treatment of late-life depression. J Clin Psychiatry 64:1065-1074, 2003   DOI   ScienceOn
2 Schwartz WB, Bennett W, Curelop S, Bartter FC. A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone: 1957. J Am Soc Nephrol 12:2860-2870, 2001
3 Wilkinson TJ, Begg EJ, Winter AC, Sainsbury R. Incidence and risk factors for hyponatraemia following treatment with fluoxetine or paroxetine in elderly people. Br J Clin Pharmacol 47:211-217, 1999
4 Kazal LA Jr, Hall DL, Miller LG, Noel ML. Fluoxetine-induced SIADH: a geriatric occurrence? J Fam Pract 36:341-343, 1993
5 Lindeman RD, Van Buren HC, Raisz LG. Osmolar renal concentrating ability in healthy young men and hospitalized patients without renal disease. N Engl J Med 262:1306-1309, 1960   DOI   ScienceOn
6 Jung AC, Staiger T, Sullivan M. The efficacy of selective serotonin reuptake inhibitors for the management of chronic pain. J Gen Intern Med 12:384-389, 1997   DOI   ScienceOn
7 Miller M. Fluid and electrolyte balance in the elderly. Geriatrics 42:65-68, 71, 75-76, 1987
8 Helderman JH, Vestal RE, Rowe JW, Tobin JD, Andres R, Robertson GL. The response of arginine vasopressin to intravenous ethanol and hypertonic saline in man: the impact of aging. J Gerontol 33:39-47, 1978   DOI   ScienceOn
9 Fabian TJ, Amico JA, Kroboth PD, Mulsant BH, Corey SE, Begley AE, Bensasi SG, Weber E, Dew MA, Reynolds CF 3rd, Pollock BG. Paroxetine-induced hyponatremia in older adults: a 12-week prospective study. Arch Intern Med 164:327-332, 2004   DOI   ScienceOn
10 Montgomery SA. A meta-analysis of the efficacy and tolerability of paroxetine versus tricyclic antidepressants in the treatment of major depression. Int Clin Psychopharmacol 16:169-178, 2001   DOI   ScienceOn
11 Yonkers KA, Lin H, Howell HB, Heath AC, Cohen LS. Pharmacologic treatment of postpartum women with new-onset major depressive disorder: a randomized controlled trial with paroxetine. J Clin Psychiatry 69:659-665, 2008   DOI   ScienceOn
12 Bartter FC. The syndrome of inappropriate secretion of antidiuretic hormone (SIADH). Dis Mon:1-47, 1973
13 Masand PS, Narasimhan M, Patkar A. Paroxetine for somatic pain associated with physical illness: a review. Prim Care Companion J Clin Psychiatry 8:122-130, 2006   DOI   ScienceOn
14 Anderson IM. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J Affect Disord 58:19-36, 2000   DOI   ScienceOn
15 Baldwin DS, Anderson IM, Nutt DJ, Bandelow B, Bond A, Davidson JR, den Boer JA, Fineberg NA, Knapp M, Scott J, Wittchen HU. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 19:567-596, 2005   DOI   ScienceOn
16 Kubota T, Miyata A. Syndrome of inappropriate secretion of antidiuretic hormone associated with paroxetine. J Anesth 20:126-128, 2006   DOI   ScienceOn
17 Malik AR, Wolf PK, Ravasia S. Recurrent paroxetine-induced hyponatremia. Can J Psychiatry 49:785, 2004
18 Wakita M, Matsuoka H, Hamada R, Okatsu H, Nakajima T, Osame M. Hyponatremia upon resumption of paroxetine therapy. Intern Med 44:240-242, 2005   DOI   ScienceOn
19 Odeh M, Seligmann H, Oliven A. Severe life-threatening hyponatremia during paroxetine therapy. J Clin Pharmacol 39:1290-1291, 1999   DOI
20 Rosner MH. Severe hyponatremia associated with the combined use of thiazide diuretics and selective serotonin reuptake inhibitors. Am J Med Sci 327:109-111, 2004   DOI   ScienceOn